1
and HP 2 , that give rise to the 3 common HP phenotypes, HP1, HP2-1, and HP2 (1, 2 ) . The HP 2 allele appears to have been generated by a 1.7-kb intragenic duplication of exons 3 and 4 of the HP 1 allele. The frequencies of the HP 1 and HP 2 genotypes vary worldwide depending on the ethnic group, with the HP 1 frequency varying from about 0.07 in parts of India to Ͼ0.7 in parts of West Africa and South America (3 ) .
Because of its polymorphic nature, HP has been used as a genetic marker for identifying parentage and individuals, and several variant phenotypes have been reported, one of which, HP Johnson, occurs at low frequency in various populations (3 ) . The molecular weight of the ␣ chain is larger (23 kDa) than that encoded by HP 2 , and Southern blotting has shown 3 tandem repeats of the same 1.7-kb DNA segment found in the HP 2 gene duplication (4 ) . Another variant, HP2-1 modified (HP2-1M), which exhibits greater HP1 protein production than HP2 because of a mutation in one of the interleukin-6 response elements in the promoter of the HP 2 allele, occurs at relatively high frequencies in African populations (5) (6) (7) . In addition, HP del , which lacks an approximately 28-kb segment of chromosome 16 that extends from the HP promoter region to exon 5 of the haptoglobin-related gene, has been identified (8, 9 ) . This allele has been found only in East and Southeast Asian populations (9 -13 ) .
Both HP 1 and HP 2 alleles have been associated with susceptibility to diabetic, cardiovascular, inflammatory, and autoimmune diseases (2 ) . Such associations may be explained by functional differences between the subtypes in the binding of hemoglobin and its rate of clearance from the plasma. Recent studies have identified profound differences between the antioxidant and immunomodulatory properties of the HP1 and HP2 polypeptides (14 ) . There are also corresponding reports of negative associations with disease (2 ). Thus, development of a simple, highthroughput HP genotyping method is needed to facilitate these association studies.
Several methods for phenotyping HP1 and HP2 have been described. High-pressure gel-permeation chromatography and gel electrophoresis methods rely on differences in the molecular sizes of HP1, HP2-1, and HP2 for typing (14, 15 ) . More recently, a singlechain antibody-based ELISA test was also established (16 ) . In addition, several HP-genotyping methods based on conventional PCR have been developed; however, these PCR-based methods need to amplify a relatively large DNA fragment to detect the 1.7-kb duplicated regions, are time-consuming, and require laborious post-PCR processing steps (8, 17, 18 ) . On the other hand, real-time PCR is a high-throughput, rapid, and sensitive method. It also eliminates post-PCR processing of PCR products, reducing the chances of carryover contamination. TaqMan assays (Applied Biosystems) use both amplification with gene-specific primers and fluorescence detection of target-specific probes. This method allows evaluation of HP RNA production or DNA genotyping of not only single-nucleotide polymorphisms but also gene dosage (19 -21 ) .
We recently developed a TaqMan-based real-time PCR method that allows differentiation of HP and HP del alleles by detecting the junctional region of the gene deletion and the promoter region of a gene that is deleted in HP del (22 ) . To detect the junctional region of the 1.7-kb intragenic duplication of HP 2 , we added the HP2 probe and primers in the TaqMan-based realtime PCR method mentioned above. This new method allows differentiation of HP 1 and HP 2 alleles by evaluation of the relative numbers of copies at the junctional region of the 1.7-kb intragenic duplication in HP 2 via comparison with the intensity of the amplification signals from an internal control (the promoter region of this gene).
Materials and Methods
The ethics committee of Kurume University School of Medicine approved this study. We used genomic DNA from 123 randomly selected Ghanaians from Accra and 7 Japanese individuals whose HP phenotypes and genotypes had previously been examined (10 ) .
We performed real-time PCR to detect 3 regions: The change in threshold cycle (⌬Ct) of each sample was calculated as the Ct value of HP5Ј (control) minus the Ct value of HP2 (target). The ⌬⌬Ct of each sample was obtained by subtracting the ⌬Ct value of the sample from the ⌬Ct value of the reference. The ⌬Ct reference value was obtained with 5 ng genomic 
Results

TRIPLEX PCR FOR HP2, HP5, AND HP del
The region chosen as the target sequence is located in the intronic sequence 5Ј of the junction region of the gene duplication of the HP 2 allele (intron 4; Fig. 1 (Fig. 2E) . Only the FAM signal was detected in the HP del /HP del DNA samples (Fig. 2F) .
PCR EFFICIENCIES FOR HP2 AND HP5
To determine the common HP genotypes, we then performed quantitative real-time PCR assays with TaqMan probes to evaluate the relative numbers of copies of the HP 2 -specific sequence. We evaluated the effect of DNA quantity on PCR efficiency in a dilution series of genomic DNA (100, 25, 6.25, 1.56, 0.39, 0.098, 0.024, and 0.0061 ng/reaction) from HP 2 (Fig. 3) . Because the efficiencies for both regions were very similar, the estimates of relative copy number obtained with these 2 Ct values were considered valid. In addition, the PCR reaction required Ͻ1 h. Thus, this method permits evaluation for both the common HP genotypes and the HP del allele. This triplex PCR system is particularly suitable for East and South Asian populations, where the HP del is observed.
VALIDATION OF THE ASSAY
To determine the quantity of genomic DNA necessary to obtain correct results, we calculated the results obtained with serially diluted samples of genomic DNA Fig. 3. HP2 and HP5 
